Found 15 matching trials
Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
PHASE3The purpose of this study was to confirm efficacy and safety of osilodrosta...
Location
University of Colorado Endocrinology Clinical Trials Unit
A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
PHASE1To characterize the pharmacokinetics of LCI699 following a single oral dose...
Location
Novartis Investigative Site
A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension
PHASE2This study determined the maximum dose of LCI6999 with respect to effect on...
Location
Impact Clinical Trials
Safety and Efficacy of LCI699 in Cushing's Disease Patients
PHASE2This exploratory study is a proof of concept study to determine whether LCI...
Location
Northwestern University Endo, Metabolism and Molecular
A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension
PHASE2This study assessed the blood pressure effect, safety and tolerability of L...
Location
Horizon Research Group, Inc
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
PHASE3The study aimed to confirm long-term efficacy and safety of LCI699 for the ...
Location
University of Colorado Hospital SC - LCI699C2301
Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome
PHASE4The purpose of this study is to continue the evaluation of long-term safety...
Location
University of Alberta Hospital - Alberta Diabetes Institute
Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
PHASE2The purpose of this study is to determine if LCI699, thorough reductions in...
Location
Novartis Investigator Site
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
PHASE2The purpose of this study is the evaluation of long-term safety of osilodro...
Location
University of Colorado
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
PHASE1To assess the pharmacokinetics of a single oral dose of osilodrostat (LCI69...
Location
University of Miami / Clinical Research Services, Inc. Boynton Beach